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INTRODUCTION
X-linked Retinoschisis (XLRS) is caused by mutations in the Retinoschisin (RS1) gene and is a leading cause for inherited macular degeneration in juvenile males.1,2 It typically manifests with foveal schisis and splitting of outer plexiform layers by ten years of age.3,4 Disease phenotype can show significant intra-familial variability.
Though the cause of this is poorly understood, 5 genetic modifiers are likely to play a role. While these remain elusive in humans, a major genetic modifier of retinoschisin1 (Mor1) has been identified using a mouse model for XLRS. 6 The RS1 gene, located on chromosome Xp22.2 has been found to be expressed exclusively in retinal tissues RS1 encodes an extracellular protein, importan in photoreceptor membrane adhesion.7 Interestingly, disease causing variants in RS1 have been found to prediminate in the the highly conserved discoidin domain. 8, 9 This domain is encoded by exons four to six of RS1 and homologous to other cell adhesion and cell signalling proteins.7,10,11 Missense mutations in RS1 generally cause protein misfolding which leads to intracellular retention and degradation of retinoschisin.12 Only one case of XLRS in females from a consanguineous family has been previously reported in the literature.13,14 We present a further consanguineous immigrant Australian family with two males, as well as two females, clinically diagnosed with XLRS and show variable disease phenotypes.
METHODS
A consanguineous Australian family, (Figure 1 
Clinical Characterisation and Electrophysiology
Nine previously unexamined family members underwent full ophthalmological examination, including dilated fundus examination. Previous clinical findings for the known affected family members were retrospectively collected on chart review. 
RESULTS
This study focussed on the clinical and molecular characterisation of a consanguineous family containing both males and females clinically diagnosed with XLRS. (Figure 1 ). This pedigree contains one non-consanguineous nuclear family with an affected male (XLRS-12) having inherited XLRS from his obligate carrier mother (XLRS-9) and maternal grandmother (XLRS-8). The second nuclear family consists of two affected females (XLRS-3, XLRS-4) presumably due to their parents consanguineous relationship (first cousins); their father (XLRS-1) has retinoschisis
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whilst their mother (XLRS-2) is thought to be a carrier, with a normal ophthalmic examination. XLRS-2 also had a previous union resulting in two clinically unaffected daughters (XLRS-5, XLRS-6). Additional, reportedly affected, family members reside in eastern Europe were not included in this study.
Molecular Genetic Findings
Sequencing of the male proband (XLRS-1, Figure 1 
Clinical Findings
Clinical findings for the four affected individuals in the pedigree studied are described in Table 1 . Of note, the females (XLRS-3 and -4) both presented from birth with high hypermetropia, accommodative esotropia and nystagmus. The proband XLRS-1 was thought to have had strabismic amblyopia from childhood, with a diagnosis of retinoschisis being made only after his daughter (XLRS-3) was diagnosed. Due to subsequent complications from the schisis and retinal detachments, XLRS-1 now meets the criteria for legally blind status. XLRS-12 also experienced a delayed diagnosis, having had reduced vision from age 6 years attributed to astigmatism. Following a blunt force head injury, he sustained a retinal Compared to the affected males, the affected females in this family were diagnosed at an earlier age, both being diagnosed with nystagmus by the age of 1 year. A similar observation was made for the previously reported consanguineous family containing affected females.13,14 The reason for this remains unclear, but may be associated with a disparate inheritance of RS1 genetic modifiers (between affected males and females), still yet to be elucidated in humans. Alternatively it is possible that there may be some other mechanism inherent to the females possessing two faulty alleles, which render them susceptible to a more severe disease phenotype. 
